A well-known pharmaceutical company, Pfizer has reached an agreement with the health department of the United States of America to produce 100 million doses of a coronavirus vaccine.
The US will be able to acquire an extra 500 million doses under the $1.95 billion deal. It is pertinent to mention here that the vaccine developers, Pfizer and BioNTech, have yet to complete phase 3 clinical trial of the vaccine to prove that it protects masses from the COVID-19.
The vaccine will be provided free of cost to the citizens of America who are affected by the viral infection. Nationwide delivery of the vaccine will begin in the end of this year, subject to its success.
In a press release, US Department of Health and Human Services Secretary Alex Azar said, “The US government is collecting different vaccines through the Operation Warp Speed program to have at least one effective coronavirus vaccine available to Americans.”
He said any vaccine bought by the US government including the Pfizer one would be given for free to Americans.
More than 20 Covid-19 vaccines are under clinical trials around the world, the World Health Organisation (WHO) said in a statement.
The Biomedical Advanced Research and Development Authority collaborated with the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense and Army Contracting Command to provide $1.95 billion for the production and nationwide delivery of the first 100 million doses of the Pfizer vaccine,.
In a separate press release, Pfizer chairman and CEO Dr Albert Bourla said they were working tireless to make an impossible possible and produce a vaccine that could end the pandemic.
“We made the early decision to begin clinical work and large-scale manufacturing at our own risk to ensure that product would be available immediately if our clinical trials prove successful and an Emergency Use Authorization is granted,” he said.